2Hans V,Rita V,Kristien R,et al.Antiseptics and disinfect-ants for the treatment of bacterial vaginosis:A systematic re-view[J].BMC Infec Dis,2012,12(1):148-165.
3Pinto E,Teixeira B,Dias G,et al.Local treatment of vulvo-vaginal candidosis:general and practical considerations[J].Drugs,2008,68(13):1787-1802.
4Zaga-Clavellina V,Ruiz M,Flores-Espinosa P,et al.Tissue-specific human beta-defensins(HBD)-1,HBD-2and HBD-3secretion profile from human amniochorionic membranesstimulated with candida albicans in a two-compartment tissueculture system[J].Reprod Biol Endocrinol,2012,10(1):170-183.
5Steubesand N,Kiehne K,Brunke G,et al.The expressionof the beta-defensins hBD-2and hBD-3is differentially regu-lated by NF-kappaB and MAPK/AP-1pathways in an in vitromodel of vulvovaginal candidiasis[J].BMC Immunol,2009,12(36):328-336.
6Chang HT,Tsai PW,Huang HH,et al.IL37and hBD-3el-evate theβ-1,3-exoglucanase activity of Candida albicansXog1p,resulting in reduced fungal adhesion to plastic[J].Biochem J,2012,441(3):963-970.
